Announced details
DDAIF has been adopted by multiple major pharmaceutical companies and has built a track record. The number of companies and the dates are not disclosed.
FRONTEO President and CEO Morimoto Masahiro (守本正宏) spoke at an American University seminar series. Capital ties, personnel ties and ordinary business relations: not disclosed.
A private university located in Washington, D.C., United States. Established in 1893 with authorization from the U.S. Congress. The university is described as being ranked among the top 10 in the United States for international relations by U.S. magazine Foreign Policy.
A total of 21 patents have been obtained in Japan, Europe, the United States and South Korea. Expiration dates and individual patent numbers: not disclosed.
American University, Washington, D.C., United States
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
U.S. magazine Foreign Policy
FRONTEO’s previous press releases
| Item | Details |
|---|---|
| Names of Products / Services Covered | Equation-driven AI platform KIBIT, Drug Discovery AI Factory（DDAIF） |
| Counterparty | American University |
| Counterparty overview | A private university located in Washington, D.C., United States. Established in 1893 with authorization from the U.S. Congress. The university is described as being ranked among the top 10 in the United States for international relations by U.S. magazine Foreign Policy. |
| Relationship with the Company | FRONTEO President and CEO Morimoto Masahiro (守本正宏) spoke at an American University seminar series. Capital ties, personnel ties and ordinary business relations: not disclosed. |
| Launch date | 10 June 2026 (local time; completed) |
| Applicable area | Scientific discovery support, Drug Discovery, Healthcare, Legal Affairs, Medical and pharmaceutical research |
| Registration number and expiry date | A total of 21 patents have been obtained in Japan, Europe, the United States and South Korea. Expiration dates and individual patent numbers: not disclosed. |
| Location | American University, Washington, D.C., United States |
| Usage history | DDAIF has been adopted by multiple major pharmaceutical companies and has built a track record. The number of companies and the dates are not disclosed. |
| Source | U.S. magazine Foreign Policy, FRONTEO’s previous press releases |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The presentation was held as part of a seminar series through which American University provides students and researchers with opportunities to learn about cutting-edge research and insights from industry.